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Abstract
Background: Current data describing the epidemiology of acute kidney injury (AKI) following repair of ruptured
abdominal aortic aneurysm (rAAA) are limited and long-term outcomes are largely unknown. Our objectives were
to describe the incidence rate, risk factors, clinical course and long-term outcomes of AKI following rAAA repair.
Methods: Retrospective population-based cohort study of all referrals undergoing emergency repair of rAAA in
Northern Alberta from January 1, 2002 to December 31 2009. Demographic, clinical, physiologic and laboratory data
were extracted. AKI was defined and classified according to the AKIN criteria.
Results: In total, 140 patients survived to receive emergent rAAA repair. Post-operative AKI occurred in 75.7% of
patients (n = 106), 78.3% (n = 83) of which occurred during the initial 24 hours of ICU admission. AKIN stage 1, 2,
and 3 occurred in 47 (33.6%), 36 (25.7%) and 23 (16.4%), respectively, with 19 patients receiving renal replacement
therapy (RRT). Several clinical and biochemical patient factors were associated with incident AKI, including baseline
estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 (odds ratio [OR] 2.94; 95% CI, 1.15-7.51, p = 0.03),
need for mechanical ventilation (OR 22.7; 95% CI, 7.0-72.1, p < 0.0001) and vasoactive therapy (OR 9.9; 95% CI,
3.0-32.2, p < 0.0001) and higher mean APACHE II scores (25.7 [8.2] vs. 16.3 [4.9], p < 0.0001). AKI was associated
with a higher ICU (28.3% vs. 0%; p = 0.0008) and in-hospital case-fatality rate (35.9% vs. 0%, p = 0.0001). Of 102
survivors to discharge, 65.7% (n = 67) recovered to baseline kidney function. In multivariable analysis, greater
severity of AKI (OR 5.01; 95% CI, 2.34-10.7, p < 0.001) and lower baseline eGFR (OR 0.96; 95% CI, 0.93-0.99, p = 0.03)
were associated with non-recovery. AKI remained independently associated with 1-year mortality after adjusting for
age, sex, comorbidity, and illness severity (OR 5.21; 95% CI, 1.04-26.2, p = 0.045; AUC 0.83; H-L GoF, p = 0.26).
Among survivors at 1-year, only 63.4% (n = 55) had complete kidney recovery.
Conclusions: Following rAAA repair, AKI is a common complication independently associated with long-term post-
operative mortality. A significant proportion of AKI sufferers in this setting fail to recover to baseline kidney function.
Background
Rupture of abdominal aortic aneurysm (rAAA) is a
relatively uncommon but devastating surgical emergency,
occurring in an estimated 5.6 persons per 100,000 popula-
tion and more common among men and older persons
[1,2]. The vast majority of patients presenting with rAAA
currently receive emergency open repair; however, the
utilization of endovascular repair has increased [3]. The
peri-operative morbidity and mortality associated with
repair of rAAA continues to be burdensome. Short-term
mortality has remained relatively stable at approximately
45-50% for open repair [4], and post-operative morbidity
remains common, with reported rates of myocardial infarc-
tion and colonic ischemia of 24% and 9% respectively, and
substantial rates of prolonged post-operative ventilatory and
vasoactive support [5,6].
In addition, acute kidney injury (AKI) remains a common
and important post-operative complication for patient
receiving either elective or emergent AAA repair, occurring
in 15-22% [7-9]. In rAAA, severe AKI requiring initiation
of renal replacement therapy (RRT) has been described in
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approximately 4-24% of cases [9,10]. Few data have
explored factors predictive of early post-operative AKI
specifically in rAAA. In small cohort studies that have
generally included both elective and ruptured AAA
patients, older age, pre-morbid chronic kidney disease
(CKD), intra-operative hypotension and low-cardiac
output, prolonged ischemic time, receipt of peri-operative
blood transfusion and post-operative rhabdomyolysis
independently predicted post-operative AKI [7-9].
Post-operative AKI has been associated with less favorable
outcomes following rAAA repair, including higher risk of
death and prolonged duration of hospitalization [9]. The
modifying impact of post-operative AKI on outcomes may
be under-appreciated in the setting of emergency proce-
dures, such as for rAAA [11]. Available data for rAAA
repair complicated by AKI have described peri-operative
mortality rates ranging 53-69% [12-14]. Importantly, very
little is known about kidney recovery in those suffering AKI
following rAAA repair [9]. This is a concerning knowledge
gap, as recent data imply a single episode of AKI independ-
ently predicts both long-term declines in survival and risk
for incident or progressive CKD [15-17]. To date, no studies
that have evaluated the long-term survival and kidney
outcomes following rAAA repair complicated by AKI.
Accordingly, our objectives were to describe, in a
population-based cohort of patients surviving repair of
rAAA (a) the incidence and spectrum in severity of AKI,
including utilization of RRT; (b) the clinical and operative
factors associated with post-operative AKI; and (c) the short
and long-term survival and kidney recovery associated
post-operative AKI.
Methods
The study protocol was approved by the Health Research
Ethics Board at the University of Alberta prior to
commencement. The requirement for written consent
was waived. The reporting of this study follows the
STROBE guideline [18].
Design, setting and participants
This was a retrospective population-based cohort study.
The study was performed in the province of Alberta,
Canada (population ~ 3.7 million in 2009). In Alberta,
there are eight geographical health zones and two
regional referral centers for all major vascular surgery.
In the five health zones comprising central and northern
Alberta (population ~ 2.0 million), all major vascular
surgery and all cases of rAAA surviving to hospital are re-
ferred to the Grey Nuns Community Hospital (GNH). For
the purpose of establishing population incidences, patient
residency in this region was confirmed by verification of
postal codes. The GNH is a university-affiliated, 347-bed
hospital in located in Edmonton, Alberta. The GNH
intensive care unit (ICU) is a closed, eight bed mixed
medical-surgical unit staffed by dedicated intensivists and
receives ~500 admissions annually. All patients with
emergent repair of rAAA are monitored and supported in
the ICU post-operatively. All adult (≥18 year) patients
admitted to the GNH with a primary diagnosis of
rAAA undergoing surgical repair during the study
period (January 2002 to December 2009 inclusive) were
eligible for inclusion; those with a pre-morbid diagnosis of
end stage kidney disease (ESKD) were excluded.
Study protocol
Patients were identified by interrogation of an ICU-specific
clinical/administrative database (Minimal Data Set [MDS]
database) between January 1, 2002 and December 31, 2009
[19]. The MDS database is maintained by the regional
Division of Critical Care Medicine, and routinely captures
demographic, clinical, physiologic and outcome data on all
admissions to the five general medical/surgical intensive
care units in Edmonton Zone. We extracted data on
patient demographics, ICU admission source, ICU admis-
sion date, post-operative status, co-morbid conditions,
necessity for mechanical ventilation, vasoactive sup-
port, Acute Physiology and Chronic Health Evaluation
(APACHE) II score [20], ICU and hospital duration of stay
and ICU, in-hospital and minimum 1-year mortality.
Individual patient medical records, including those of the
index hospitalization as well as previous and post-discharge
visits in survivors, were also interrogated for additional
clinical, pharmacologic (i.e. pre-admission prescription
medications), physiologic and laboratory data, along with
operative/anesthesia records (i.e. procedure duration, blood
loss, and transfusions).
Operational definitions
Patients were said to have a history of hypertension,
coronary artery disease (CAD), stroke or smoking if
these were documented in their medical record. Presence
of diabetes mellitus (DM) was defined by prior documenta-
tion in the medical record or by an admission HbA1c
≥6.5%. Urine output data were available for the 24 hours
after ICU admission. Oliguria was defined as a urine output
< 400 mL/24 hour. cTnI was measured using the Beckman-
coulter assay which detects the presence of cTnI at a
threshold concentration of 0.15 mcg/L [21]. Any cTnI
≥0.15 mcg/L was designated a positive result (TnI+).
Baseline serum creatinine was the value documented
in the 6-months prior to the index hospital admission
and was available for all included patients. Baseline
estimated glomerular filtration rate (eGFR) was calculated
using the CKD-EPI equation [22].
Acute kidney injury (AKI) occurring in association with
rAAA was defined according to the serum creatinine-
based criteria of the Acute Kidney Injury Network (AKIN)
classification system [23]. The diagnosis of AKI was
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confirmed for any patient with a >26.5 μmol/L increment
in serum creatinine within a 48 hour period following
presentation or a 1.5 fold increment in serum creatinine
relative to the pre-hospital baseline creatinine value. Peak
post-operative creatinine relative to pre-hospital baseline
creatinine was used to assign severity stage of AKI.
Complete renal recovery was defined as return to within
10% of baseline creatinine. Non-recovery was defined
as < 10% decline from peak serum creatinine following
AKI and/or RRT dependence at the time of death or
hospital discharge. Partial recovery was defined as a reduc-
tion of >10% in serum creatinine from peak value, but with
a final value >10% above baseline. Renal recovery, i.e.,
complete, partial, or none, was assessed at time of
hospital discharge or death for hospital non-survivors.
For those discharged without complete recovery of
baseline renal function, renal recovery was re-evaluated
at one-year following hospital discharge.
Statistical analyses
Clinical variables and univariate comparison between
groups are reported for normally or near normally
distributed variables as means with standard deviations
(SD) and compared by Student’s t-test or analysis of
variance (ANOVA) and for non-normally distributed
continuous data as medians with inter-quartile ranges
(IQR) and compared by Mann Whitney U test or
Kruskal Wallis test, respectively. Categorical data are
reported as proportions and compared using Fisher’s Exact
Test. Customized, multiple variable logistic regression
models were created, using mortality or renal recovery as
dependent variables, that considered age, sex, pre-existing
chronic kidney disease, APACHE II score; blood loss/blood
transfusion, mechanical ventilation, vasopressor use, renal
replacement therapy (RRT) and post-operative AKI as
covariates. Data are reported as odds ratios (OR) with 95%
confidence intervals (CI). Model calibration and fit were
assessed by the area under the receiver operating character-
istic curve (AUC) and the Hosmer-Lemeshow goodness of
fit (GoF) test, respectively. Crude survival stratified by study
group was assessed graphically by the Kaplan-Meier prod-
uct limit estimator and compared with the log-rank test. A
p-value of < 0.05 was considered statistically significant for
all comparisons. Analysis was performed using Intercooled
Stata Release 10 (Stata Corp, College Station, TX).
Results
Epidemiology and patient characteristics
In total, 142 patients presented with a primary diagnosis
of rAAA and received operative repair during the study
period, of which, two were excluded due to pre-
morbid ESKD. This represented a population-based
incidence of 11.9 events per million population per
year (95% CI, 9.9-14.1; n = 133; n = 7 excluded due to
primary postal address located outside the defined
geographic catchment). The incidence of rAAA increased
by an estimated 6.9% per million year (95% CI, 5.9-13.2,
p = 0.04) over the study period.
Of these, 96.4% (n = 135) received open operative
repair with the remaining undergoing endovascular repair.
Among all patients (n = 140), mean (SD) age was 71.1
(8.8) years, 85.0% (n = 119) were male, 70.7% (n = 99) had
hypertension and 91.1% (n = 113) had a smoking history.
Mean (SD) pre-morbid eGFR was 65.8 (19.9) mL/min/
1.73 m2 and 33.6% (n = 47) had an eGFR < 60 mL/min/
1.73 m2 at baseline (Table 1).
Incidence and peri-operative factors associated with AKI
The cumulative incidence of AKI, defined by the AKIN cri-
teria, was 75.7% (n = 106). Of these, 78.3% (n = 83) fulfilled
AKIN criteria within 24 hours after ICU admission. AKIN
stage 1, 2 and 3 occurred in 47 (33.6%), 36 (25.7%) and 23
(16.4%), respectively. The median (IQR) time to maximum
AKIN stage was 1 day (0–5). RRT was received by 19
patients (13.6%). Of these, the majority (n = 13, 56.5%)
achieved AKIN stage 3 (Tables 1 and 2).
Several factors were found associated with post-operative
AKI including a baseline eGFR < 60 mL/min/1.73 m2
(odds ratio [OR] 2.94; 95% CI, 1.15-7.51, p = 0.03),
greater intra-operative blood loss (3.9 [3.6] vs. 1.8
[1.4] L, p = 0.002), and greater number of units of
transfused red cells (9 [5–14] vs. 2 [0–4] units, p < 0.001).
In addition, patients developing AKI were more likely to be
supported with mechanical ventilation (OR 22.7; 95% CI,
7.0-72.1, p < 0.0001), vasoactive therapy (OR 9.9; 95% CI,
3.0-32.2, p < 0.0001) and had higher illness severity scores
(p < 0.0001). Post-operatively, AKI patients had lower
serum pH (p = 0.002), lower serum hematocrit (p = 0.001),
higher serum sodium (p < 0.001), higher serum potas-
sium (p = 0.001), and were more likely to have elevated
cardiac-specific troponin-I values (p < 0.001) (Table 1).
Several trends were apparent in stratifying patients by
severity of kidney injury (Table 2). With more severe
AKI, the proportion of patients with a detectable cTnI
increased (p = 0.05), as did the likelihood of receiving
vasoactive support (p = 0.002) and RRT (p = 0.001).
Hospital outcomes
Overall, crude ICU and in-hospital mortality were
21.4% (n = 30) and 27.1% (n = 38), respectively. AKI
was associated with a higher unadjusted ICU (28.3%
vs. 0%; p = 0.0008) and in-hospital case-fatality rate
(35.9% vs. 0%, p = 0.0001), compared to those with no
AKI. In addition, post-operative AKI, stratified by severity,
was associated with a dose–response increase in duration
of ICU and hospital stay (Table 2). The unadjusted
long-term survival stratified by post-operative AKI is
shown in Figure 1.
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Renal recovery
Of 102 (72.9%) survivors to hospital discharge, the
majority had complete recovery of kidney function (Table 3).
Factors associated with partial or non-recovery of kidney
function included greater illness severity (p = 0.005), lower
pre-morbid eGFR (p = 0.03), greater severity of AKI
(p < 0.001), and longer duration to peak serum creatinine
(p < 0.001) (Figure 2). In multivariable analysis, only
greater severity of AKI (OR 5.01; 95% CI, 2.34-10.7,
p < 0.001) and lower baseline eGFR (OR 0.96; 95% CI,
0.93-0.99, p = 0.03) were independently associated
with partial or non-recovery of function, after adjustment
for demographics, comorbidities, and illness severity
(AUC 0.85; H-L GoF, p = 0.28).
Table 1 Summary of baseline characteristics, intra-operative parameters and acute physiologic stratified by AKI status
Parameter Total AKI No AKI p
n, % 140 106 (75.7) 34 (24.3) -
Age (years) [mean [SD]) 71.1 (8.8) 71.6 (8.0) 69.7 (10.9) 0.27
Male Sex (n, %) 119 (85.0) 88 (83.0) 31 (91.2) 0.41
Co-morbid disease
Hypertension (n, %) 99 (70.7) 77 (72.6) 22 (64.7) 0.39
Coronary artery disease (n, %) 50 (35.2) 37 (35.2) 13 (39.4) 0.68
Stroke (n, %) 14 (10.1) 10 (9.5) 4 (11.8) 0.75
Diabetes Mellitus (n, %) 24 (17.1) 20 (18.9) 4 (11.8) 0.44
Ever smoked (n, %) 113 (91.1) 82 (90.1) 31 (93.9) 0.73
Baseline eGFR (mean [SD]) 65.8 (19.9) 63.1 (20.1) 74.1 (17.0) 0.005
Baseline eGFR < 60 mL/min/1.73 m2 (n, %) 47 (33.6) 41 (38.7) 6 (17.7) 0.04
Pre-operative Medications
HMG-CoA Reductase Inhibitor (n, %) 42 (31.1) 33 (32.4) 9 (27.3) 0.67
ACE inhibitor/ARB (n, %) 46 (34.1) 35 (34.1) 11 (33.3) 1.0
Beta-blocker (n, %) 39 (28.9) 26 (25.5) 13 (39.4) 0.18
Intra-operative variables
Operative Duration (min) (mean [SD]) 228 (74) 221 (69) 261 (92) 0.03
Supra-renal Aortic Clamp (n, %) 22 (16.7) 17 (17.0) 5 (15.6) 1.0
Estimated blood loss (L) (mean [SD]) 3.4 (3.2) 3.9 (3.6) 1.8 (1.4) 0.002
Red cell transfusion (units) (median [IQR]) 7 (3–12) 9 (5–14) 2 (0–4) < 0.0001
Post-operative variables
Mechanical ventilation (n, %) 120 (85.7) 102 (96.2) 18 (52.9) < 0.001
Vasoactive support (n, %) 54 (40.6) 51 (50.5) 3 (9.4) < 0.001
APACHE II score (mean [SD]) 23.4 (8.5) 25.7 (8.2) 16.3 (4.9) < 0.001
MAP (mm Hg) (mean [SD]) 63.4 (13.8) 62.5 (14.6) 66.1 (11.3) 0.18
Heart rate (beats/min) (mean [SD]) 111 (21) 113 (21) 103 (15) 0.01
PaO2 (cm H2O) (mean [SD]) 72.9 (28.4) 73.2 (31.5) 72.0 (15.5) 0.82
PaCO2 (cm H2O) (mean [SD]) 41.9 (7.2) 42.5 (7.6) 39.9 (5.6) 0.06
pH (mean [SD]) 7.26 (0.10) 7.24 (0.10) 7.31 (0.07) 0.002
Hematocrit (mean [SD]) 0.276 (0.05) 0.267 (0.05) 0.305 (0.04) 0.001
White cell count (cells/109) (mean [SD]) 12.8 (4.4) 12.8 (4.5) 12.9 (4.3) 0.92
Serum sodium (mmol/L) (mean [SD]) 142 (4.0) 143 (3.6) 140 (3.0) < 0.001
Serum potassium (mmol/L) (mean [SD]) 4.9 (0.9) 5.0 (0.9) 4.5 (0.5) 0.001
Serum glucose (mmol/L) (mean [SD]) 10.1 (2.9) 10.4 (2.9) 9.1 (2.2) 0.01
Serum troponin-I elevation (n, %) 78 (55.7) 69 (65.1) 9 (26.5) < 0.001
Abbreviations: APACHE II = Acute Physiology and Chronic Health Evaluation; eGFR = estimated glomerular filtration rate; ACE = angiotensin converting enzyme;
ARB = angiotensin receptor blocker; MAP = mean arterial pressure.
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Long-term outcome
At 1-year, cumulative mortality was 33.6% (n = 47/140).
Post-operative AKI was associated with higher 1-year
mortality (42.3% vs. 5.9%; OR 11.8; 95% CI, 3.0 - ∞,
p < 0.0001). In multi-variable analysis, AKI remained
independently associated with 1-year mortality (OR
5.21; 95% CI, 1.04-26.2, p = 0.045; AUC 0.83; H-L
GoF, p = 0.26) after adjusting for age, sex, comorbidity,
and illness severity. Of survivors, 63.4% (n = 55) had
complete recovery, 27.9% (n = 26) had partial recovery,
and 8.6% (n = 8) patients had non-recovery of function.
Discussion
We performed a population-based cohort study of all
patients in a large geographic region surviving rAAA to
receive operative repair to describe the incidence, risk
factors and associated mortality and renal recovery of
post-operative AKI.
Key findings
We found the incidence of rAAA in Northern Alberta
was approximately 11.9 per million population per year,
which increased significantly during the study by 6.9%
per million per year. We found the cumulative incidence
of AKI to be high at 75.7%, with the majority of episodes
occurring within the first 1–2 days of surgery. Of these,
16.4% achieved AKIN Stage 3 and 13.6% received RRT.
Post-operative AKI was associated with several factors
including illness severity, intra-operative blood loss, and
greater intensity of post-operative support (i.e. mechanical
ventilation, vasoactive therapy). We also found both
short-term and long-term mortality and resource
utilization were greater for with post-operative AKI.
Despite this, we also found that among survivors,
most completely recovered kidney function. Those
not recovering were more likely to have more severe
AKI and impaired baseline kidney function.
Interpretation and context with prior literature
The post-operative incidence of AKI following rAAA has
been reported to range between 20-46%; however, these
rates are often defined in small cohorts of elective or mixed
elective/emergency patients [10,12-14,24]. In addition, an
accurate estimate of the burden of post-operative AKI has
been hindered by the variable definitions applied to diag-
nosis AKI. Many studies have defined AKI simply by post-
operative receipt of RRT, utilization of ICD-9 codes and/or
various changes or thresholds in post-operative serum
creatinine [7,9,10,14]. The use of post-operative RRT will
better define the health resource utilization associated with
more severe forms of AKI; however, this approach remains
susceptible to bias due to the inconsistent thresholds and
practice variation for when and if to start RRT [25]. We
believe our study is the largest to explore the incidence of
Table 2 Summary of kidney function and outcomes stratified by severity of AKI
All No AKI AKIN stage 1 AKIN stage 2 AKIN stage 3 P¶
(n = 140) (n = 34) (n = 47) (n = 36) (n = 23)
Baseline SCr (μmol/L) (median [IQR]) 92 (81–110) 89 (80–103) 98 (83–118) 87 (80–112) 100 (85–124) 0.12
Baseline eGFR < 60 mL/min/1.73 m2 (no, %) 50 (35.5) 11 (26.2) 20 (42.6) 12 (38.7) 7 (33.3) 0.424
Baseline eGFR (mL/min/1.73 m2) (mean [SD]) 65 (21) 71 (19) 60 (22) 67 (21) 63 (18) 0.078
Urine output (24 hr) (mL) (mean [SD]) 1642 (1165) 1970 (852) 1809 (1315) 1357 (1234) 1266 (978) 0.04
Oliguria (< 400 mL/24 hr) (n, %) 16 (11.5) 0 (0) 3 (6.5) 8 (22.2) 5 (21.7) 0.003
Peak SCr (μmol/L) (median [IQR]) 169 (123–277) 102 (90–122) 155 (135–190) 219 (175–262) 460 (358–460) 0.0001
Delta SCr (baseline to peak) (μmol/L) (median [IQR]) 77 (31–139) 15 (4–22) 55 (42–80) 127 (94–148) 370 (278–464) 0.0001
Time to Peak SCr (d) (median [IQR]) 1 (0–5) - 1 (0–2) 1 (0–3) 6 (2–15) 0.0001
RRT (n, %) 19 (13.6) 0 (0) 2 (4.3) 4 (11.1) 13 (56.5) < 0.001
Discharge SCr (μmol/L) (median [IQR]) 107 (83–184) 82 (73–90) 108 (86–108) 112 (83–194) 244 (148–412) 0.0001
Discharge SCr* (μmol/L) (median [IQR]) 87 (79–112) 82 (73–90) 96 (85–112) 85 (73–112) 168 (116–278) 0.0001
Delta SCr (baseline to discharge)* (μmol/L) (median [IQR]) 1 (−9 – 16) 6 (−9 – 13) 0 (−2 – 26) 24 (0–96) 92 (42–189) 0.0001
RRT at hospital discharge (n, %) 4 (17.4) 0 (0) 0 (0) 0 (0) 4 (17.4) 0.001
ICU Mortality (n, %) 30 (21.4) 0 (0) 11 (23.4) 12 (33.3) 7 (30.4) < 0.001
Hospital Mortality (n, %) 38 (27.1) 0 (0) 13 (27.6) 14 (38.9) 11 (47.8) < 0.001
ICU stay (d) (median [IQR]) 4 (2–9) 3 (2–5) 3 (1–7) 4 (2–10) 14 (7–23) < 0.001
Hospital stay (d) (median [IQR]) 11 (7–19) 9 (7–11) 10 (7–16) 11 (3–24) 23 (13–32) < 0.001
Abbreviations: SCr = serum creatinine; eGFR = estimated glomerular filtration rate; RRT = renal replacement therapy.
*Survivors and RRT independent.
¶ P-value for comparison across groups.
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post-operative AKI in patients receiving operative repair
for rAAA. Using the AKIN criteria, we found a much
higher incidence of AKI among rAAA patients than
previously reported.
Prior literature has characterized a number of asso-
ciative factors for post-operative AKI in elective AAA
repair including: pre-morbid chronic kidney disease,
procedural duration and kidney ischemic time; intra-
operative hypotension, blood transfusion, rhabdomyolysis,
low cardiac output syndrome, and post-operative treatment
intensity (i.e. vasoactive therapy) [7,8,26]. Our results
confirm these prior findings, showing longer operative
duration, greater intra-operative blood loss and illness
severity portend an increased risk for post-operative AKI.
Several studies have suggested less favorable outcomes
for patients undergoing aortic aneurysm repair whose
post-operative course is complicated by AKI, in particu-
lar when requiring RRT, with mortality rates in excess of
60% [7,8,12,14]. Recent data have also suggested even
mild AKI not requiring RRT portends an increased risk
for post-operative mortality [26]. We confirmed that
AKI was associated with a dose–response increase in
risk for death that persisted beyond index hospitalization
among survivors.
It has been demonstrated that even non-RRT-dependent
AKI influences long-term health outcomes, conferring
increased risks of renal and non-renal outcomes, including
mortality [17,27,28]. The long-term impact of AKI on
renal function was recently demonstrated in a large cohort
of patients undergoing major vascular surgery, which
found that both transient and persistent renal dysfunction
in the peri-operative period were independent predictors
of the development of CKD [29]. There is limited data on
renal recovery after AKI following rAAA, and much of it
has defined “recovery” as RRT- independence, an insensi-
tive definition. Residual renal insufficiency following
episodes of RRT-dependent AKI in this setting has been
reported in small cohorts [10,12]. Consistent with this,
our data highlight that a proportion of patients with
peri-operative AKI develop persistent kidney dysfunction
following the event. Similar to our findings, others have
described a correlation between severity of AKI, gauged by
the degree of rise in serum creatinine, and failure to recover
baseline kidney function or progression to CKD [15,30].
Recent literature has suggested that duration of AKI may
be an even stronger prognosticator than severity [30,31],
although we did not find a later peak in serum creatinine to
be independently associated with renal outcomes.
Limitations
Our study has several noteworthy limitations. First, we
omitted patients with rAAA who died prior to presenting
to hospital or were not referred for surgery. This may have
unduly influenced our incidence estimate. Second, consid-
ering that rAAA is relatively uncommon, our cohort was
small and as such, our analyses are subject to limited statis-
tical power and errors of chance. However, our study is
strengthened by a population-based cohort design. Third,
we did not have detailed data on the duration of time from
diagnosis to operative repair and recognize this may repre-
sent an important confounding factor for the association of
AKI, intra-operative variables and mortality. Fourth, in our
Figure 1 Kaplan-Meier survival curve stratified by post-operative AKI.
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application of the AKIN criteria for AKI, we used the
serum creatinine criteria only, due to urine output beyond
the first 24 hours being variably documented. This may
have also unduly influenced our incidence estimates for
AKI. Fifth, we recognize the sole use of serum-creatinine
based definitions for renal recovery may misclassify
complete or partial recovery in patients with complicated
post-operative courses, where suboptimal nutrition and loss
of lean muscle mass may undermine creatinine as an accur-
ate measure of GFR. Finally, the utilization of RRT was not
Figure 2 Renal recovery status at hospital discharge stratified by baseline estimated glomerular filtration rate.
Table 3 Risk factors for non-recovery of kidney function at hospital discharge or death among patients with AKI
All patients (n = 102) Complete RR (n = 67) Partial RR (n = 26) Non-recovery (n = 9) P¶
Age (years) (mean [SD]) 69.9 (9.2) 69.8 (9.9) 69.1 (7.7) 73.7 (7.3) 0.43
APACHE II score (mean [SD]) 20.4 (6.3) 19.0 (5.9) 23.7 (6.5) 21.1 (5.5) 0.005
Stage 3 AKI (no, %) 12 (11.8) 0 (0) 6 (23.1) 6 (66.7) < 0.001
Male Sex (no, %) 87 (85.3) 60 (89.6) 21 (80.8) 6 (66.7) 0.10
Hypertension (no, %) 71 (69.6) 46 (68.6) 17 (65.4) 8 (88.9) 0.41
CAD (no, %) 37 (37) 21 (32.3) 13 (50.0) 3 (33.3) 0.30
Diabetes Mellitus (no, %) 13 (12.8) 9 (13.4) 3 (11.54) 1 (11.1) 1.0
Pre-op statin (no, %) 28 (28.0) 15 (23.1) 12 (46.2) 1 (11.1) 0.049
Pre-op ACEI (no, %) 30 (30.0) 17 (26.2) 11 (42.3) 2 (22.2) 0.30
Pre-op BB (no, %) 30 (30.0) 19 (29.2) 9 (34.6) 2 (22.2) 0.79
Baseline eGFR (mL/min/1.73 m2) (mean [SD]) 70.6 (17.6) 73.6 (17.3) 66.6 (15.6) 59.5 (20.8) 0.03
Baseline eGFR < 60 mL/min/1.73 m2 (no, %) 25 (24.1) 14 (20.9) 6 (23.1) 5 (55.6) 0.09
Vasopressors in ICU (no, %) 25 (25.8) 15 (23.8) 5 (20.0) 5 (55.6) 0.12
Troponin (+) ve (no, %) 42 (65.6) 20 (62.5) 18 (78.3) 4 (44.4) 0.16
Time to peak SCr (day) (median [IQR]) 1 (0–5) 0 (0–1) 3 (1–6) 5 (5–13) < 0.001
OR duration (min) (median [IQR]) 225 (180–285) 225 (173–270) 210 (180–285) 240 (180–285) 0.85
RRT (no, %) 8 (7.8) 1 (1.5) 3 (11.5) 4 (44.4) < 0.001
Abbreviations: AKI = acute kidney injury; CAD = coronary artery disease; eGFR = estimated glomerular filtration rate; OR = operating room; RRT = renal
replacement therapy.
¶ P-value for comparison across groups.
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necessarily standardized and clinical judgment and practice
may have varied between clinicians.
Conclusions
In summary, we present a population-based cohort of
rAAA patients surviving to hospital to undergo operative
repair, found a high incidence of post-operative AKI, and
demonstrated its association with less favorable post-
operative outcomes. Our data provide important informa-
tion for prognostication and insight into factors associated
with this clinical event. Importantly, a proportion of AKI
sufferers in our cohort failed to recover baseline renal func-
tion, both at the time of hospital discharge and at one year
following the event, indicating lasting morbidity. As the
population of survivors of rAAA grows, our findings both
inform those involved in its acute management, and
imply the importance of appropriate follow-up to address
long-term health consequences of the event.
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